HTL Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- HTL Biotechnology's estimated annual revenue is currently $36.3M per year.
- HTL Biotechnology's estimated revenue per employee is $155,000
Employee Data
- HTL Biotechnology has 234 Employees.
- HTL Biotechnology grew their employee count by 22% last year.
HTL Biotechnology's People
| Name | Title | Email/Phone |
|---|
HTL Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 81 | -5% | N/A | N/A |
#2 | $19.5M | 126 | -2% | N/A | N/A |
#3 | $36.3M | 234 | 22% | N/A | N/A |
#4 | $19.7M | 127 | -17% | N/A | N/A |
#5 | $14.3M | 92 | 0% | $179.5M | N/A |
#6 | $49.4M | 208 | -8% | €201.1M | N/A |
#7 | $44.5M | 287 | -3% | N/A | N/A |
#8 | $7.6M | 49 | N/A | N/A | N/A |
#9 | $6.4M | 41 | N/A | N/A | N/A |
#10 | $17.2M | 111 | -15% | N/A | N/A |
What Is HTL Biotechnology?
HTL Biotechnology Manufacture and Research & Development of Hyaluronan and other Biological Polymers by bacterial fermentation HTL Biotechnology was created in 1992 and is specialized in the manufacture, purification and research and development of Hyaluronan (HA). Today it has diversified and produces other biological polymers (see new products) for the pharmaceutical and medical fields. Commited to top level injectable requirements for biological polymers Full cGMP facility inspected by European authorities and US FDA Support and Dossier for Product registration worldwide Dedicated R&D support team with major biological polymer expertise
keywords:N/A
N/A
Total Funding
234
Number of Employees
$36.3M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HTL Biotechnology News
Bloomage Biotech, Focus Chem, Fufeng Group, AWA Biopharm, China Eastar Group, Kewpie, Contipro, Seikagaku, HTL Biotechnology,...
HTL produces GAGs by biofermentation, an alternative to animal extraction that maintains the quality required for pharmaceutical grade, allowing...